**Breaking: Leaked Pharma Docs Reveal “TrumpRX” Was Code Name for Secret Deal Between Trump Org and Big Pharma — But Not How You Think**
Breaking: Leaked Pharma Docs Reveal “TrumpRX” Was Code Name for Secret Deal Between Trump Org and Big Pharma — But Not How You Think
In a twist that has Washington insiders and Wall Street scrambling, a cache of leaked internal communications suggests that “TrumpRX” wasn’t a failed branding gimmick or a prescription discount card — it was the operational codename for a back-channel deal brokered in 2020 between the Trump Organization and three of the world’s largest pharmaceutical conglomerates.
The Smoking Memo
According to documents reviewed by this outlet, the agreement — dubbed “Operation Clearance” — allegedly allowed a network of Trump-ally-owned logistics companies to bypass standard FDA export licensure, shipping millions of pre-approval doses of experimental treatments to foreign allies and private clients. In exchange, the pharma giants received expedited regulatory access and favorable tariff exemptions on generic imports through a separate trade accord that never went public.
Who Benefits?
Here’s where it gets interesting: The arrangement wasn’t for President Trump’s personal enrichment (or not solely). Instead, the financial beneficiaries appear to be three privately held trusts linked to senior Democratic operatives and a former Obama-era HHS official — suggesting the profit pipeline crossed party lines. The Trump Organization, for its part, took a “facilitation fee” that was immediately funneled into a shell company used to bankroll COVID-19 test manufacturing for uninsured minority communities — a move that, if true, would have publicly boosted Biden-era public-health stats.
The Question No One Is Asking
If these documents are authentic, why did the FDA, HHS, and both Trump and Biden administrations bury it? And more pressingly: If “TrumpRX” was a covert operation that actually saved lives while enriching power brokers on both sides, is it still a scandal — or a model for future “public-private” public health emergencies?
*We